Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT07326085

Pilot Study to Evaluate the Feasibility, Adherence and Acceptance of the MiDiálisis Platform for Patients on PD

Led by Aida Frías González · Updated on 2026-01-08

55

Participants Needed

1

Research Sites

70 weeks

Total Duration

On this page

Sponsors

A

Aida Frías González

Lead Sponsor

S

Spanish Society of Nephrology

Collaborating Sponsor

AI-Summary

What this Trial Is About

The main goal of this study is to assess whether a mobile phone app called MiDiálisis is practical, easy to use, and well-accepted. The app was developed by the Technical University of Madrid (UPM) and is designed to bring together the clinical data of people with chronic kidney disease who are on peritoneal dialysis. This way, both patients and doctors can access the information at any time.

CONDITIONS

Official Title

Pilot Study to Evaluate the Feasibility, Adherence and Acceptance of the MiDiálisis Platform for Patients on PD

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients over 18 years of age
  • Patients with chronic kidney disease who have been on peritoneal dialysis for at least 3 months at the same hospital
  • Patients with stable clinical condition for the past 3 months, with no unscheduled hospitalizations or major cardiovascular events
  • Availability of a smartphone or tablet and internet access for the patient or caregiver
  • Patients who understand the study and provide signed informed consent
Not Eligible

You will not qualify if you...

  • Patients with limitations for multifrequency body composition measurement, including those with pacemakers, implantable cardioverter defibrillators, or who are pregnant
  • Patients who do not routinely use a smartphone or are unfamiliar with mobile apps
  • Patients scheduled for a living kidney transplant in the next 6 months
  • Patients with life expectancy under 6 months
  • Patients enrolled in a peritoneal ultrafiltration program due to cardiorenal syndrome

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Hospital 12 de Octubre

Madrid, Madrid, Spain, 28041

Actively Recruiting

Loading map...

Research Team

A

Aida Frias, MD

CONTACT

P

Paula Jara Caro Espada, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SEQUENTIAL

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here